Other Viruses Citation List: August 29 - September 11, 2014
Hepatitis B Virus
1. Human microRNA hsa-miR-1231 Suppresses Hepatitis B Virus Replication by Targeting Core mRNA. Kohno, T., M. Tsuge, E. Murakami, N. Hiraga, H. Abe, D. Miki, M. Imamura, H. Ochi, C.N. Hayes, and K. Chayama. Journal of Viral Hepatitis, 2014. 21(9): p. e89-e97. PMID[24835118].
[PubMed]. OV_0829-091114.
2. In Vitro and in Vivo anti-Hepatitis B Virus Activities of the Lignan Niranthin Isolated from Phyllanthus niruri L. Liu, S., W. Wei, K. Shi, X. Cao, M. Zhou, and Z. Liu. Journal of Ethnopharmacology, 2014. 155(2): p. 1061-1067. PMID[25009077].
[PubMed]. OV_0829-091114.
3. Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents. Ochi, A., E. Ishimura, M. Ichii, Y. Ohno, S. Nakatani, I. Kobayashi, H. Shima, A. Tsuda, K. Shidara, K. Mori, A. Tamori, and M. Inaba. Nephrology, 2014. 19(9): p. 595-596. PMID[25156438].
[PubMed]. OV_0829-091114.
4. Differential Binding of Tenofovir and Adefovir to Reverse Transcriptase of Hepatitis B Virus. van Hemert, F.J., B. Berkhout, and H.L. Zaaijer. PLoS One, 2014. 9(9): p. e106324. PMID[25180507].
[PubMed]. OV_0829-091114.
5. A New Series of HAPs as anti-HBV Agents Targeting at Capsid Assembly. Yang, X.Y., X.Q. Xu, H. Guan, L.L. Wang, Q. Wu, G.M. Zhao, and S. Li. Bioorganic & Medicinal Chemistry Letters, 2014. 24(17): p. 4247-4249. PMID[25127104].
[PubMed]. OV_0829-091114.
Hepatitis C Virus
6. Structure-activity Studies of (-)-Epigallocatechin Gallate Derivatives as HCV Entry Inhibitors. Bhat, R., A.T. Adam, J.J. Lee, G. Deloison, Y. Rouille, K. Seron, and D.P. Rotella. Bioorganic & Medicinal Chemistry Letters, 2014. 24(17): p. 4162-4165. PMID[25103601].
[PubMed]. OV_0829-091114.
7. Cyclohexane-fused Octahydroquinolizine Alkaloids from Myrioneuron faberi with Activity against Hepatitis C Virus. Cao, M.M., Y. Zhang, X.H. Li, Z.G. Peng, J.D. Jiang, Y.C. Gu, Y.T. Di, X.N. Li, D.Z. Chen, C.F. Xia, H.P. He, S.L. Li, and X.J. Hao. Journal of Organic Chemistry, 2014. 79(17): p. 7945-7950. PMID[25101523].
[PubMed]. OV_0829-091114.
8. Benzhydrylpiperazine Compounds Inhibit Cholesterol-dependent Cellular Entry of Hepatitis C Virus. Chamoun-Emanuelli, A.M., E.I. Pecheur, and Z. Chen. Antiviral Research, 2014. 109: p. 141-148. PMID[25019406].
[PubMed]. OV_0829-091114.
9. Ombitasvir: A Potent Pan-genotypic Inhibitor of NS5A for the Treatment of Hepatitis C Virus Infection. Gentile, I., A.R. Buonomo, and G. Borgia. Expert Review of Anti-infective Therapy, 2014. 12(9): p. 1033-1043. PMID[25074011].
[PubMed]. OV_0829-091114.
10. Synthesis and Inhibitory Activity on Hepatitis C Virus RNA Replication of 4-(1,1,1,3,3,3-Hexafluoro-2-hydroxy-2-propyl)aniline Analogs. Matsuno, K., Y. Ueda, M. Fukuda, K. Onoda, M. Waki, M. Ikeda, N. Kato, and H. Miyachi. Bioorganic & Medicinal Chemistry Letters, 2014. 24(17): p. 4276-4280. PMID[25086684].
[PubMed]. OV_0829-091114.
11. Activity of Core-modified 10-23 DNAzymes against HCV. Robaldo, L., A. Berzal-Herranz, J.M. Montserrat, and A.M. Iribarren. ChemMedChem, 2014. 9(9): p. 2172-2177. PMID[25079672].
[PubMed]. OV_0829-091114.
12. Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-acting Antiviral Agents. Wose Kinge, C.N., C. Espiritu, N. Prabdial-Sing, N.P. Sithebe, M. Saeed, and C.M. Rice. Antimicrobial Agents and Chemotherapy, 2014. 58(9): p. 5386-5394. PMID[24982066].
[PubMed]. OV_0829-091114.
Herpes Simplex Virus 1
13. Oligonucleotides Designed to Inhibit TLR9 Block Herpes Simplex Virus Type 1 Infection at Multiple Steps. Sauter, M.M., J.J. Gauger, and C.R. Brandt. Antiviral Research, 2014. 109: p. 83-96. PMID[24995383].
[PubMed]. OV_0829-091114.
Citations from the ISI Web of Knowledge Listings for O.V.
14. A Novel Human Radixin Peptide Inhibits Hepatitis C Virus Infection at the Level of Cell Entry. Bukong, T.N., K. Kodys, and G. Szabo. International Journal of Peptide Research and Therapeutics, 2014. 20(3): p. 269-276. ISI[000339820500002].
[WOS]. OV_0809-091114.
15. Recombinant Human L-Ficolin Directly Neutralizes Hepatitis C Virus Entry. Hamed, M.R., R.J.P. Brown, C. Zothner, R.A. Urbanowicz, C.P. Mason, A. Krarup, C.P. McClure, W.L. Irving, J.K. Ball, M. Harris, T.P. Hickling, and A.W. Tarr. Journal of Innate Immunity, 2014. 6(5): p. 676-684. ISI[000340345900012].
[WOS]. OV_0809-091114.
16. Selective Inhibitor of Histone Deacetylase 6 (Tubastatin A) Suppresses Proliferation of Hepatitis C Virus Replicon in Culture of Human Hepatocytes. Kozlov, M.V., A.A. Kleymenova, K.A. Konduktorov, A.Z. Malikova, and S.N. Kochetkov. Biochemistry (Moscow), 2014. 79(7): p. 637-642. ISI[000340553200005].
[WOS]. OV_0829-091114.